SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?
Por um escritor misterioso
Descrição
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
Depression and the NMDA receptor/NO/cGMP pathway - ScienceDirect
Preso regulates NMDA receptor-mediated excitotoxicity via
Delivering medicines for depression and central nervous system
Alteration of NMDA receptor trafficking as a cellular hallmark of
Blockade of NMDA receptor or NMDA-DAPK1 downstream signaling
SciELO - Brazil - Does mismatch negativity have utility for NMDA
Cell-type specific modulation of NMDA receptors triggers
Signaling pathways responsible for the rapid antidepressant-like
Iridoids from Gardeniae fructus ameliorates depression by
PDF) Using the pharmacology of latent inhibition to model domains
SciELO - Brazil - Does mismatch negativity have utility for NMDA
PDF) Neuroprogression in schizophrenia: Pathways underpinning
PDF) Changing prevalence and treatment of depression among older
de
por adulto (o preço varia de acordo com o tamanho do grupo)
